Activity of the multikinase inhibitor dasatinib against ovarian cancer cells

被引：0
作者：
G E Konecny
R Glas
J Dering
K Manivong
J Qi
R S Finn
G R Yang
K-L Hong
C Ginther
B Winterhoff
G Gao
J Brugge
D J Slamon
机构：
[1] David Geffen School of Medicine,Division of Hematology
[2] University of California Los Angeles,Oncology, Department of Medicine
[3] Mayo Clinic,Division of Gynecologic Surgery, Department of Obstetrics and Gynecology
[4] Harvard Medical School,Department of Cell Biology
来源：
British Journal of Cancer | 2009年 / 101卷
关键词：
Src; Eph2A; FAK; uPA; dasatinib; ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1699 / 1708
页数：9
相关论文
共 50 条
  • [31] Dasatinib sensitises KRAS-mutant cancer cells to mitogen-activated protein kinase kinase inhibitor via inhibition of TAZ activity
    Rao, Guanhua
    Kim, In-Kyu
    Conforti, Fabio
    Liu, Jing
    Zhang, Yu-Wen
    Giaccone, Giuseppe
    EUROPEAN JOURNAL OF CANCER, 2018, 99 : 37 - 48
  • [32] Dasatinib can enhance paclitaxel and gemcitabine inhibitory activity in human pancreatic cancer cells
    Ma, Ling
    Wei, Jia
    Su, Gloria H.
    Lin, Jiayuh
    CANCER BIOLOGY & THERAPY, 2019, 20 (06) : 855 - 865
  • [33] Synergistic activity of the histone deacetylase inhibitor trichostatin A and the proteasome inhibitor PS-341 against taxane-resistant ovarian cancer cell lines
    Jin, Xin
    Fang, Yong
    Hu, Yi
    Chen, Jing
    Liu, Wei
    Chen, Gang
    Gong, Mei
    Wu, Peng
    Zhu, Tao
    Wang, Shixuan
    Zhou, Jianfeng
    Wang, Hui
    Ma, Ding
    Li, Kezhen
    ONCOLOGY LETTERS, 2017, 13 (06) : 4619 - 4626
  • [34] Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells
    Carmi, Yifat Koren
    Agbarya, Abed
    Khamaisi, Hazem
    Farah, Raymond
    Shechtman, Yelena
    Korobochka, Roman
    Gopas, Jacob
    Mahajna, Jamal
    TRANSLATIONAL ONCOLOGY, 2024, 44
  • [35] Anti-Cancer Activity of Cannabis sativa Phytocannabinoids: Molecular Mechanisms and Potential in the Fight against Ovarian Cancer and Stem Cells
    Koltai, Hinanit
    Shalev, Nurit
    CANCERS, 2022, 14 (17)
  • [36] EGFR inhibition studies by hybrid scaffolds for their activity against ovarian cancer
    Zhang, Feng
    Zhang, Hongyan
    Wang, Fang
    JOURNAL OF BUON, 2016, 21 (06): : 1482 - 1490
  • [37] Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
    Guo, Jing
    Zeng, Xiaozhu
    Zhu, Yongjie
    Yang, Dong
    Zhao, Xudong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [38] Effect of dasatinib on EMT-mediated-mechanism of resistance against EGFR inhibitors in lung cancer cells
    Sesumi, Yuichi
    Suda, Kenichi
    Mizuuchi, Hiroshi
    Kobayashi, Yoshihisa
    Sato, Iatsuaki
    Chiba, Masato
    Shimoji, Masaki
    Tomizawa, Kenji
    Takemoto, Toshiki
    Mitsudomi, Tetsuya
    LUNG CANCER, 2017, 104 : 85 - 90
  • [39] Antitumor activity of 7RH, a discoidin domain receptor 1 inhibitor, alone or in combination with dasatinib exhibits antitumor effects in nasopharyngeal carcinoma cells
    Lu, Qiu-Ping
    Chen, Wen-Dan
    Peng, Jie-Ren
    Xu, Yao-Dong
    Cai, Qian
    Feng, Gong-Kan
    Ding, Ke
    Zhu, Xiao-Feng
    Guan, Zhong
    ONCOLOGY LETTERS, 2016, 12 (05) : 3598 - 3608
  • [40] Differential Targeting of Gr-MDSCs, T Cells and Prostate Cancer Cells by Dactolisib and Dasatinib
    Liu, Guoqiang
    Jin, Zhijian
    Lu, Xin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (07)
12345